Efficacy and safety of artemether–lumefantrine for the treatment of uncomplicated falciparum malaria at sentinel sites in Mozambique, 2015

Acta Tropica

Volumn 171, Issue , 2017, Pages 146-150

  Salvador, Crizolgo ^a   Rafael, Bernardete ^a   Matsinhe, Francisco ^b   Candrinho, Baltazar ^b   Muthemba, Rosália ^b   De Carvalho, Eva ^c   Naueia, Eva ^d   Sacarlal, Jahit ^e   Namboze, Josephine ^c   Tiago, Armindo ^e   Warsame, Marian ^c   Enosse, Sónia ^a  

^a INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

^b Ministerio da Saude   (Mozambique)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d Fundação Ariel Glaser   (Mozambique)

^e EDUARDO MONDLANE UNIVERSITY   (Mozambique)

Author keywords

Artemeter lumefantrine; Efficacy and safety; Mozambique; Plasmodium falciparum

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; HEMOGLOBIN; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

CHILD HEALTH; DISEASE CONTROL; DISEASE TREATMENT; DRUG PRESCRIBING; EFFICIENCY MEASUREMENT; MALARIA; POLYMERASE CHAIN REACTION; SAFETY;

ABSENCE OF SIDE EFFECTS; ARTICLE; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GENE; GENETIC ANALYSIS; GLURP GENE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MOZAMBIQUE; MSP1 GENE; MSP2 GENE; PARASITOLOGY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROSPECTIVE STUDY; REINFECTION; WORLD HEALTH ORGANIZATION; DRUG COMBINATION; GENETICS; INFANT; PLASMODIUM FALCIPARUM; RECURRENT DISEASE;

MOZAMBIQUE;

PLASMODIUM FALCIPARUM;

ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MOZAMBIQUE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RECURRENCE;

EID: 85017230678     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2017.03.032     Document Type: Article

References (22)

1. Abuaku, B., Duah, N., Quaye, L., Quashie, N., Malm, K., Bart-Plange, C., Koram, K., Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations in the treatment of uncomplicated malaria in two ecological zones in Ghana. Malar. J., 15, 2016, 67.
2. Adeel, A.A., Saeed, N.A., Aljasari, A., Almohager, A.M., Galab, M.H., AlMahdi, A., Mahammed, M.H., AlDarsi, M., Salaeah, Y.A., Atta, H., Zamani, G., Warsame, M., Barrette, A., Mohammady, H.E., Nada, R.A., High efficacy of two artemisinin-based combinations: artesunate + sulfadoxine-pyrimethamine and artemether-lumefantrine for falciparum malaria in Yemen. Malar. J., 14, 2015, 449.
3. Ariey, F., Witkowski, B., Amaratunga, C., Beghain, J., Langlois, A.C., Khim, N., Kim, S., Duru, V., Bouchier, C., Ma, L., Lim, P., Leang, R., Duong, S., Sreng, S., Suon, S., Chuor, C.M., Bout, D.M., Ménard, S., Rogers, W.O., Genton, B., Fandeur, T., Miotto, O., Ringwald, P., Le Bras, J., Berry, A., Barale, J.C., Fairhurst, R.M., Benoit-Vical, F., Mercereau-Puijalon, O., Ménard, D., A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505 (2014), 50–55.
4. Ashley, E.A., Dhorda, M., Fairhurst, R.M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J.M., Mao, S., Sam, B., Sopha, C., Chuor, C.M., Nguon, C., Sovannaroth, S., Pukrittayakamee, S., Jittamala, P., Chotivanich, K., Chutasmit, K., Suchatsoonthorn, C., Runcharoen, R., Hien, T.T., Thuy-Nhien, N.T., Thanh, N.V., Phu, N.H., Htut, Y., Han, K.T., Aye, K.H., Mokuolu, O.A., Olaosebikan, R.R., Folaranmi, O.O., Mayxay, M., Khanthavong, M., Hongvanthong, B., Newton, P.N., Onyamboko, M.A., Fanello, C.I., Tshefu, A.K., Mishra, N., Valecha, N., Phyo, A.P., Nosten, F., Yi, P., Tripura, R., Borrmann, S., Bashraheil, M., Peshu, J., Faiz, M.A., Ghose, A., Hossain, M.A., Samad, R., Rahman, M.R., Hasan, M.M., Islam, A., Miotto, O., Amato, R., MacInnis, B., Stalker, J., Kwiatkowski, D.P., Bozdech, Z., Jeeyapant, A., Cheah, P.Y., Sakulthaew, T., Chalk, J., Intharabut, B., Silamut, K., Lee, S.J., Vihokhern, B., Kunasol, C., Imwong, M., Tarning, J., Taylor, W.J., Yeung, S., Woodrow, C.J., Flegg, J.A., Das, D., Smith, J., Venkatesan, M., Plowe, C.V., Stepniewska, K., Guerin, P.J., Dondorp, A.M., Day, N.P., White, N.J., Tracking Resistance to Artemisinin Collaboration (T.R.A.C) spread of artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 371 (2014), 411–423.
5. Dambe, R., Sande, J., Ali, D., Chilima, B., Dodoli, W., Michelo, C., Malenga, G., Phiri, K.S., Monitoring the efficacy of artemether-lumefantrine for the treatment of uncomplicated malaria in Malawian children. Malar. J., 14, 2015, 175.
6. Dondorp, A.M., Nosten, F., Yi, P., Das, D., Phyo, A.P., Tarning, J., Lwin, K.M., Ariey, F., Hanpithakpong, W., Lee, S.J., Ringwald, P., Silamut, K., Imwong, M., Chotivanich, K., Lim, P., Herdman, T., An, S.S., Yeung, S., Singhasivanon, P., Day, N.P., Lindegardh, N., Socheat, D., White, N.J., Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361 (2009), 455–467.
7. Getnet, G., Fola, A.A., Alemu, A., Getie, S., Fuehrer, H.P., Noedl, H., Therapeutic efficacy of artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Enfranze, north-west Ethiopia. Malar. J., 14, 2015, 258.
8. Hamainza, B., Masaninga, F., Moonga, H., Mwenda, M., Chanda-kapata, P., Chalwe, V., Chanda, E., Kamuliwo, M., Babaniyi, O.A., Therapeutic efficacy of artemether-lumefantrine on treatment of uncomplicated Plasmodium falciparum mono-infection in an area of high malaria transmission in Zambia. Malar. J., 13, 2014, 430.
9. Inquérito demográfico saúde 2011 [Demographic health survey 2011]. Luanda. 2011 ( www.ine.gov.mz/operacoes.../inqueritos/inquerito-demografico-e-de-saude/ids.../pdf).
10. Korenromp, E.L., Armstrong-Schellenberg, J.R., Williams, B.G., Nahlen, B.L., Snow, R.W., Impact of malaria control on childhood anaemia in Africa – a quantitative review. Trop. Med. Int. Health 9 (2004), 1050–1065.
11. Leang, R., Taylor, W.R.J., Bouth, D.M., Song, L., Tarning, J., Char, M.C., Kim, S., Witkowski, B., Duru, V., Domergue, A., Khim, N., Ringwald, P., Menard, D., Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment. Antimicrob. Agents Chemother. 59 (2015), 4719–4726.
12. Ndounga, M., Mayengue, Pembe Issamou, Casimiro, P.N., Koukouikila-Koussounda, F., Bitemo, M., Diassivy Matondo, M., Diassivy Matondo, B., Ndounga Diakou, L.A., Basco, L.A., Ntoumi, F., Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10 years old living in a suburban area: a randomized study. Malar. J., 14, 2015, 423.
13. Nhama, A., Bassat, Q., Enosse, S., Nhacolo, A., Mutemba, R., Carvalho, E., Naueia, E., Sevene, E., Guinovart, C., Warsame, M., Sanz, S., Mussa, A., Matsinhe, G., Alonso, P., Tiago, A., Macete, E., In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique. Malar. J., 13, 2014, 390.
14. Plucinski, M.M., Dimbu, P.R., Macaia, A.P., Ferreira, C.M., Samutondo, C., Quivinja, J., Afonso, M., Kiniffo, R., Mbounga, E., Kelley, J.S., Patel, D.S., He, Y., Talundzic, E., Garrett, D.O., Halsey, E.S., Udhayakumar, V., Ringwald, P., Fortes, F., Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015. Malar. J., 16, 2017, 62.
15. Sowunmi, A., Akano, K., Ayede, A.I., Ntadom, G., Adewoye, E.O., Fatunmbi, B., Aderoyeje, T., Therapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in Nigerian children aged two years and under. Infect. Dis. Poverty, 6(5), 2016, 70.
16. Takala-Harrison, S., Jacob, C.G., Arze, C., Cummings, M.P., Silva, J.C., Dondorp, A.M., Fukuda, M.M., Hien, T.T., Mayxay, M., Noedl, H., Nosten, F., Kyaw, M.P., Nhien, N.T., Imwong, M., Bethell, D., Se, Y., Lon, C., Tyner, S.D., Saunders, D.L., Ariey, F., Mercereau-Puijalon, O., Menard, D., Newton, P.N., Khanthavong, M., Hongvanthong, B., Starzengruber, P., Fuehrer, H.P., Swoboda, P., Khan, W.A., Phyo, A.P., Nyunt, M.M., Nyunt, M.H., Brown, T.S., Adams, M., Pepin, C.S., Bailey, J., Tan, J.C., Ferdig, M.T., Clark, T.G., Miotto, O., MacInnis, B., Kwiatkowski, D.P., White, N.J., Ringwald, P., Plowe, C.V., Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in south East Asia. J. Infect. Dis. 211 (2015), 670–679.
17. WHO, Antimalarial Drug Combination Therapy. Report of a WHO Technical Consultation., 2001, World Health Organization, Geneva.
18. WHO, Methods for Surveillance of Antimalarial Drug Efficacy 2009. 2009, World Health Organization, Geneva.
19. WHO, Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000–2010., 2010, World Health Organization, Geneva.
20. WHO, Guidelines for the Treatment of Malaria. 2015, World Health Organization, Geneva.
21. WHO, World Malaria Report 2016., 2016, World Health Organization, Geneva.
22. WHO, Artemisinin and Artemisinin-based Combination Therapy Resistance: Status Report., 2016, World Health Organization, Geneva.